Condition: Mitral Regurgitation · Valvular Heart Disease · Heart Failure · Sponsor: Inova Health Care Services
The overarching goal of this research proposal is to study the feasibility and clinical impact of implementing an Inova system-wide heart failure treatment algorithm for patients with symptomatic heart failure due to reduced left ventricular ejection fraction (HFreF) and secondary MR Aim is to check the effectiveness of the IHFTA in identifying patients who are most likely to benefit from percutaneous transcatheter Mitraclip repair in real world
This description comes directly from the study's public registry record.
Hassan Saeed · (703) 776-5716 · hassan.saeed@inova.org
Mahira Awan · (703) 776-5716 · mahira.awan@inova.org
Always discuss trial participation with your own doctor first.
| Inova Fairfax Medical Campus | Falls Church, Virginia, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06675448